Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim for COVID-19 Associated Acute Hypoxemia
NCT04411680Phase 2Completed
- Start
- Aug 2020
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in coronavirus disease 2019 (COVID-19). Started Aug 2020; status: completed.
02
Drugs
sargramostim
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04411680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411680.